Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What Are Wall Street Analysts' Target Price for Insulet Stock?

Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. Valued at a market capitalization of $17.1 billion, the company offers the Omnipod platform, comprising the Omnipod 5 automated insulin delivery system and the Omnipod DASH insulin management system.

The company's shares have underperformed the broader market over the past year and in 2026. PODD stock has declined 12.2% over the past 52 weeks and 13.3% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 11.9% over the past year and declined marginally in 2026.

Fundamentals

See More
  • Market Capitalization, $K 17,329,280
  • Shares Outstanding, K 70,347
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 437 M
  • EBITDA $ 518 M
  • 60-Month Beta 1.41
  • Price/Sales 7.11
  • Price/Cash Flow 54.71
  • Price/Book 12.34

Options Overview Details

View History
  • Implied Volatility 35.18% (-15.38%)
  • Historical Volatility 37.84%
  • IV Percentile 43%
  • IV Rank 33.06%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 2) 10.31 (3.83%)
  • Put/Call Vol Ratio 0.15
  • Today's Volume 415
  • Volume Avg (30-Day) 221
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 8,827
  • Open Int (30-Day) 7,265
  • Expected Range 259.02 to 279.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.48
  • Number of Estimates 10
  • High Estimate 1.86
  • Low Estimate 1.32
  • Prior Year 1.15
  • Growth Rate Est. (year over year) +28.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
240.03 +10.74%
on 02/06/26
288.98 -8.02%
on 01/21/26
-21.90 (-7.61%)
since 01/16/26
3-Month
240.03 +10.74%
on 02/06/26
354.88 -25.10%
on 11/20/25
-67.67 (-20.29%)
since 11/18/25
52-Week
230.05 +15.54%
on 03/10/25
354.88 -25.10%
on 11/20/25
-14.91 (-5.31%)
since 02/18/25

Most Recent Stories

More News
Stocks Rally on Signs of US Economic Resilience

The S&P 500 Index ($SPX ) (SPY ) today is up +0.84%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.20%. March E-mini S&P futures (ESH26...

AMAT : 372.23 (+3.65%)
B : 48.50 (+3.97%)
KNF : 91.93 (-2.17%)
HL : 22.81 (+7.39%)
GPN : 79.51 (+13.96%)
CDE : 23.04 (+5.64%)
ADI : 348.42 (+3.23%)
GLBE : 33.88 (+14.07%)
$IUXX : 25,021.97 (+1.30%)
ASML : 1,470.29 (+3.56%)
ZNH26 : 112-310 (-0.14%)
ESH26 : 6,920.25 (+0.87%)
Stocks Climb on Solid US Economic News and Easing AI Jitters

The S&P 500 Index ($SPX ) (SPY ) today is up +0.36%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.40%. March E-mini S&P futures (ESH26...

B : 48.50 (+3.97%)
KNF : 91.93 (-2.17%)
HL : 22.81 (+7.39%)
GPN : 79.51 (+13.96%)
CDE : 23.04 (+5.64%)
ADI : 348.42 (+3.23%)
DDOG : 121.81 (-0.61%)
GLBE : 33.88 (+14.07%)
$IUXX : 25,021.97 (+1.30%)
FIGR : 37.42 (+1.38%)
ZNH26 : 112-310 (-0.14%)
ESH26 : 6,920.25 (+0.87%)
Insulet: Q4 Earnings Snapshot

Insulet: Q4 Earnings Snapshot

PODD : 259.97 (+5.53%)
What Are Wall Street Analysts' Target Price for Insulet Stock?

Insulet has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

XLV : 157.03 (-0.22%)
$SPX : 6,899.28 (+0.82%)
PODD : 259.97 (+5.53%)
Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales

Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales

PODD : 259.97 (+5.53%)
Insulet Reports Fourth Quarter and Full Year 2025 Results

Fourth Quarter 2025 Revenue Increase of 31% (29% Constant Currency 1 ) and Full Year 2025 Revenue Increase of 31% Year-Over-Year (30%...

PODD : 259.97 (+5.53%)
Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow

Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow

PODD : 259.97 (+5.53%)
3 Profitable Stocks for Long-Term Investors

3 Profitable Stocks for Long-Term Investors

IBTA : 21.25 (+5.30%)
CSW : 307.85 (+4.68%)
PODD : 259.97 (+5.53%)
2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges

2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges

DV : 9.55 (+2.47%)
PAY : 24.43 (+4.09%)
PODD : 259.97 (+5.53%)
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors ...

PODD : 259.97 (+5.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 257.41
2nd Resistance Point 253.53
1st Resistance Point 249.93
Last Price 259.97
1st Support Level 242.46
2nd Support Level 238.58
3rd Support Level 234.99

See More

52-Week High 354.88
Fibonacci 61.8% 307.19
Fibonacci 50% 292.46
Fibonacci 38.2% 277.74
Last Price 259.97
52-Week Low 230.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar